Gainers
- Castle Biosciences CSTL stock increased by 44.3% to $19.16 during Friday's pre-market session. The company's market cap stands at $511.3 million.
- ZyVersa Therapeutics ZVSA shares rose 40.29% to $0.34. The company's market cap stands at $7.9 million.
- T2 Biosystems TTOO shares rose 23.13% to $0.1. The company's market cap stands at $2.5 million.
- Bluejay Diagnostics BJDX stock moved upwards by 17.98% to $0.25. The market value of their outstanding shares is at $5.2 million.
- Longeveron LGVN shares rose 12.91% to $3.39. The market value of their outstanding shares is at $71.6 million.
- BiomX PHGE stock increased by 12.81% to $0.43. The market value of their outstanding shares is at $19.5 million.
Losers
- Cadrenal Therapeutics CVKD shares decreased by 12.8% to $1.3 during Friday's pre-market session. The company's market cap stands at $15.2 million.
- Comera Life Sciences CMRA shares declined by 9.94% to $0.5. The company's market cap stands at $11.2 million.
- Incannex Healthcare IXHL stock declined by 7.11% to $1.96. The market value of their outstanding shares is at $124.4 million.
- CytoMed Therapeutics GDTC stock fell 6.75% to $3.04. The market value of their outstanding shares is at $35.0 million.
- Intelligent Bio Solutions INBS shares declined by 6.45% to $2.58. The company's market cap stands at $6.0 million.
- Hoth Therapeutics HOTH shares declined by 5.95% to $2.85. The market value of their outstanding shares is at $9.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CMRAComera Life Sciences Holdings Inc
$0.055127450.0%
CSTLCastle Biosciences Inc
$28.045.22%
CVKDCadrenal Therapeutics Inc
$15.003.52%
GDTCCytoMed Therapeutics Ltd
$3.40-%
HOTHHoth Therapeutics Inc
$0.76001.59%
INBSIntelligent Bio Solutions Inc
$1.421.32%
IXHLIncannex Healthcare Inc
$2.05-3.30%
LGVNLongeveron Inc
$1.73-%
PHGEBiomX Inc
$0.76074.19%
TTOOT2 Biosystems Inc
$0.4100-2.38%
ZVSAZyVersa Therapeutics Inc
$1.081.89%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in